BackgroundTumor genomes are often highly heterogeneous, consisting of genomes from multiple subclonal types. Complete characterization of all subclonal types is a fundamental need in tumor genome analysis. With the advancement of next-generation sequencing, computational methods have recently been developed to infer tumor subclonal populations directly from cancer genome sequencing data. Most of these methods are based on sequence information from somatic point mutations, However, the accuracy of these algorithms depends crucially on the quality of the somatic mutations returned by variant calling algorithms, and usually requires a deep coverage to achieve a reasonable level of accuracy.ResultsWe describe a novel probabilistic mixture model...
Tumours accumulate many somatic mutations in their lifetime. Some of these mutations, drivers, conve...
Tumors are heterogeneous in the sense that they consist of multiple subpopulations of cells, referre...
Abstract Mutational signatures are key to understanding the processes that shape cancer genomes, yet...
BackgroundTumor genomes are often highly heterogeneous, consisting of genomes from multiple subclona...
Multistage tumorigenesis is a dynamic process characterized by the accumulation of mutations. Thus, ...
Cancer is a genetic disease characterized by the emergence of genetically distinct populations of ce...
Multistage tumorigenesis is a dynamic process characterized by the accumulation of mutations. Thus, ...
Whole-genome sequencing can be used to estimate subclonal populations in tumours and this intra-tumo...
Abstract Background Tumor samples are heterogeneous. They consist of varying cell populations or sub...
Tumor DNA sequencing data can be interpreted by computational methods that analyze genomic heterogen...
We present SVclone, a computational method for inferring the cancer cell fraction of structural vari...
Tumor DNA sequencing data can be interpreted by computational methods that analyze genomic heterogen...
Improving our understanding of intra-tumour heterogeneity in cancer has important clinical implicati...
We present SVclone, a computational method for inferring the cancer cell fraction of structural vari...
Most tumors are composed of a heterogeneous population of subclones. A more detailed insight into th...
Tumours accumulate many somatic mutations in their lifetime. Some of these mutations, drivers, conve...
Tumors are heterogeneous in the sense that they consist of multiple subpopulations of cells, referre...
Abstract Mutational signatures are key to understanding the processes that shape cancer genomes, yet...
BackgroundTumor genomes are often highly heterogeneous, consisting of genomes from multiple subclona...
Multistage tumorigenesis is a dynamic process characterized by the accumulation of mutations. Thus, ...
Cancer is a genetic disease characterized by the emergence of genetically distinct populations of ce...
Multistage tumorigenesis is a dynamic process characterized by the accumulation of mutations. Thus, ...
Whole-genome sequencing can be used to estimate subclonal populations in tumours and this intra-tumo...
Abstract Background Tumor samples are heterogeneous. They consist of varying cell populations or sub...
Tumor DNA sequencing data can be interpreted by computational methods that analyze genomic heterogen...
We present SVclone, a computational method for inferring the cancer cell fraction of structural vari...
Tumor DNA sequencing data can be interpreted by computational methods that analyze genomic heterogen...
Improving our understanding of intra-tumour heterogeneity in cancer has important clinical implicati...
We present SVclone, a computational method for inferring the cancer cell fraction of structural vari...
Most tumors are composed of a heterogeneous population of subclones. A more detailed insight into th...
Tumours accumulate many somatic mutations in their lifetime. Some of these mutations, drivers, conve...
Tumors are heterogeneous in the sense that they consist of multiple subpopulations of cells, referre...
Abstract Mutational signatures are key to understanding the processes that shape cancer genomes, yet...